The optimal dosing of gemtuzumab ozagamicin: where to go from here?
Publication year
2016Source
Haematologica, 101, 6, (2016), pp. 653-4ISSN
Publication type
Article / Letter to editor
Display more detailsDisplay less details
Organization
Haematology
Tumorimmunology
Journal title
Haematologica
Volume
vol. 101
Issue
iss. 6
Page start
p. 653
Page end
p. 4
Subject
Radboudumc 2: Cancer development and immune defence RIMLS: Radboud Institute for Molecular Life SciencesThis item appears in the following Collection(s)
- Academic publications [246625]
- Electronic publications [134196]
- Faculty of Medical Sciences [93367]
- Open Access publications [107722]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.